← Human Trials & Peer-Reviewed Studies

Specialized High-Protein Oral Nutrition Supplement Improves Home Nutrient Intake of Malnourished Older Adults Without Decreasing Usual Food Intake.

Plain-language guide to PMID 30565718 (2019): randomized controlled trial of Copper (Supplement).

Key Facts

PMID
30565718
Journal
JPEN. Journal of parenteral and enteral nutrition
Year
2019
Study type
Randomized Controlled Trial
Authors
Loman BR et al. (8 authors)
DOI
10.1002/jpen.1467

What This Study Did, in Plain Language

What Was Tested

Researchers studied Copper (Supplement) in this randomized controlled trial publication.

This study examines the impact of a high-protein oral nutrition supplement (S-ONS) on nutrient intake post discharge.

Who Took Part

The age groups tagged for this paper are older adults, both men and women.

In a subset of patients (14 S-ONS and 16 placebo) from the NOURISH (Nutrition effect On Unplanned ReadmIssions and Survival in Hospitalized patients) trial, 24-hour dietary recalls were conducted on 3 randomly selected days during the weeks of 30, 60, and 90 days post discharge.

How the Study Was Run

In design terms this was a randomized and placebo-controlled study.

Because people in this Copper (Supplement) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

A placebo (an inactive look-alike) gave the Copper (Supplement) group a baseline to be compared against.

Nutrient intake was estimated using Nutrition Data System for Research software.

Dietary Reference Intakes (DRIs) were used for other nutrients.

What Was Measured

PubMed files the paper under topics including Diet Surveys, Dietary Supplements, Eating, Energy Intake, Feeding Behavior, Geriatric Assessment and Hospitalization.

The authors tagged it with the keywords malnutrition, minerals/trace element intake, nutrient intake, oral nutrition supplement and vitamin intake.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Copper (Supplement).

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2019 (JPEN. Journal of parenteral and enteral nutrition), a journal based in United States.

More context: the Copper (Supplement) compound page, all human trials.

Our Notes on the Compound

Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.